Nickel Sensitivity
6
1
1
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
Interleukin-2 (IL-2), Interleukin-5 (IL-5) and Interleukin-17 (IL-17) Levels of Patients With Stainless Steel Crowns
Investigation of Nickel Sensitization After Percutaneous Implantation of Patent Foramen Ovale Occluder
The Immunological Profile of Nickel Dermatitis
Hydroponic Cultivation in Systemic Nickel Allergy Syndrome
Systemic Nickel Allergy Syndrome: Intervention Study for the Assessment of the Dietary Indications